INTELLIA THERAPEUTICS, INC. Shares Issued
INTELLIA THERAPEUTICS, INC. (NTLA) had Shares Issued of 140.02 million shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesIssued · last filed 2026-08-06
- 2026-06-30: Common Stock, Shares, Issued 140.02M shares.
- 2026-03-31: Common Stock, Shares, Issued 120.45M shares.
- 2025-12-31: Common Stock, Shares, Issued 116.32M shares.
- 2025-09-30: Common Stock, Shares, Issued 115.79M shares.
| Period end | Common Stock, Shares, Issued | Common Stock, Shares, Issued as first filed |
|---|---|---|
| 2026-06-30 | 140.02M shares 10-Q · filed 2026-08-06 | |
| 2026-03-31 | 120.45M shares 10-Q · filed 2026-05-11 | |
| 2025-12-31 | 116.32M shares 10-Q · filed 2026-08-06 | |
| 2025-09-30 | 115.79M shares 10-Q · filed 2025-11-06 | |
| 2025-06-30 | 105.33M shares 10-Q · filed 2025-08-07 | |
| 2025-03-31 | 103.54M shares 10-Q · filed 2025-05-08 | |
| 2024-12-31 | 102.03M shares 10-K · filed 2026-02-26 | |
| 2024-09-30 | 101.80M shares 10-Q · filed 2024-11-07 | |
| 2024-06-30 | 98.29M shares 10-Q · filed 2024-08-08 | |
| 2024-03-31 | 96.33M shares 10-Q · filed 2024-05-09 | |
| 2023-12-31 | 93.00M shares 10-K · filed 2025-02-27 | |
| 2023-09-30 | 89.10M shares 10-Q · filed 2023-11-09 | |
| 2023-06-30 | 88.35M shares 10-Q · filed 2023-08-03 | |
| 2023-03-31 | 88.10M shares 10-Q · filed 2023-05-04 | |
| 2022-12-31 | 87.10M shares 10-K · filed 2024-02-22 | |
| 2022-09-30 | 76.59M shares 10-Q · filed 2022-11-03 | |
| 2022-06-30 | 76.00M shares 10-Q · filed 2022-08-04 | |
| 2022-03-31 | 75.62M shares 10-Q · filed 2022-05-05 | |
| 2021-12-31 | 74.49M shares 10-K · filed 2023-02-23 | |
| 2021-09-30 | 74.34M shares 10-Q · filed 2021-11-04 | |
| 2021-06-30 | 68.33M shares 10-Q · filed 2021-08-05 | |
| 2021-03-31 | 67.89M shares 10-Q · filed 2021-05-06 | |
| 2020-12-31 | 66.23M shares 10-K · filed 2022-02-24 | |
| 2020-09-30 | 58.79M shares 10-Q · filed 2020-11-05 | |
| 2020-06-30 | 58.72M shares 10-Q · filed 2020-08-06 | |
| 2020-03-31 | 50.60M shares 10-Q · filed 2020-05-07 | |
| 2019-12-31 | 66.23M shares 10-K · filed 2021-02-26 | 50.20M shares 10-K · filed 2020-02-27 |
| 2019-09-30 | 48.88M shares 10-Q · filed 2019-10-31 | |
| 2019-06-30 | 47.71M shares 10-Q · filed 2019-08-01 | |
| 2019-03-31 | 45.48M shares 10-Q · filed 2019-05-02 | |
| 2018-12-31 | 45.22M shares 10-K · filed 2020-02-27 | |
| 2018-09-30 | 43.37M shares 10-Q · filed 2018-10-31 | |
| 2018-06-30 | 43.19M shares 10-Q · filed 2018-08-01 | |
| 2018-03-31 | 43.09M shares 10-Q · filed 2018-05-01 | |
| 2017-12-31 | 42.38M shares 10-K · filed 2019-02-27 | |
| 2017-09-30 | 36.09M shares 10-Q · filed 2017-10-31 | |
| 2017-06-30 | 36.06M shares 10-Q · filed 2017-08-01 | |
| 2017-03-31 | 36.03M shares 10-Q · filed 2017-05-02 | |
| 2016-12-31 | 36.02M shares 10-K · filed 2018-03-14 | |
| 2016-09-30 | 36.00M shares 10-Q · filed 2016-11-01 | |
| 2016-06-30 | 36.00M shares 10-Q · filed 2016-08-04 | |
| 2016-03-31 | 2.56M shares 10-Q · filed 2016-06-03 | |
| 2015-12-31 | 2.56M shares 10-K · filed 2017-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |